ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Chronic Obstructive Pulmonary Disease
Obstructive Lung Diseases
Allergic Rhinitis
Nasal Polyps
Respiration Disorders
Respiratory Tract Diseases

Asthma trials near Nashville, TN, USA:

A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype (SWIFT-2)

This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma...

Active, not recruiting
Asthma
Biological: GSK3511294 (Depemokimab)
Biological: Placebo

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Hendersonville, Tennessee, United States and 141 other locations

To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied pop...

Enrolling
Asthma
Drug: Tezepelumab

Phase 4

AstraZeneca
AstraZeneca

Hendersonville, Tennessee, United States and 44 other locations

of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...

Enrolling
Asthma
Biological: Placebo
Biological: Mepolizumab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Hendersonville, Tennessee, United States and 429 other locations

variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...

Enrolling
Asthma
Drug: BFF pMDI 320/9 μg
Drug: BGF MDI 320/14.4/9.6 μg

Phase 3

AstraZeneca
AstraZeneca

Hendersonville, Tennessee, United States and 446 other locations

variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...

Enrolling
Asthma
Drug: BFF pMDI 320/9 μg
Drug: BFF MDI 320/9.6 μg

Phase 3

AstraZeneca
AstraZeneca

Franklin, Tennessee, United States and 479 other locations

respiratory disease (AERD). AERD is a disease that involves asthma, recurring nasal polyps, and respiratory reactions to aspirin and other n...

Active, not recruiting
Asthma, Aspirin-Induced
Drug: Ifetroban Oral Capsule
Drug: Placebo Oral Capsule

Phase 2

Cumberland Pharmaceuticals
Cumberland Pharmaceuticals

Nashville, Tennessee, United States and 15 other locations

This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheez...

Enrolling
Wheezing Lower Respiratory Illness
Recurrent Wheezing
Drug: Placebo
Drug: OM-85

Phase 2

OM Pharma

Nashville, Tennessee, United States and 30 other locations

The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected...

Enrolling
Advanced Unresectable Solid Tumor
Metastatic Solid Tumor
Drug: Toripalimab
Drug: TAB004

Phase 1

TopAlliance Biosciences

Nashville, Tennessee, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems